Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 506-509, May 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabourel, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabourel, J. D.

Cell Culture in Vivo. II. Behavior of L-Fibroblasts in Diffusion Chambers in Resistant Hosts*

John D. Gabourel

( Department of Pharmacology, Stanford University School of Medicine, Palo Alto, Calif.)

The growth of L-fibroblasts in diffusion chambers implanted intraperitoneally in C3H mice was inhibited by "hyperimmunizing" the host with L-fibroblasts; no significant inhibition was found while reactions analogous to first-set and second-set rejections presumably were occurring in the host outside the diffusion chamber. The serum from "hyperimmunized" C3H mice contained a diffusible (soluble) factor(s) which, when injected into isologous mice, inhibited the growth of L-fibroblasts in diffusion chambers in these animals. These results are consistent with the hypothesis that a circulating growth-inhibitory factor(s), presumably an antibody, may play an important role in the rejection of fibroblast-type cells as well as leukotic-type cells.

* Supported by American Cancer Society Grants T38 and T39 to Dr. Avram Goldstein.

With the Technical Assistance of Ester Bugna

Received 10/ 3/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.